Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
30.5M
-
Shares change
-
+558K
-
Total reported value, excl. options
-
$3.42B
-
Value change
-
+$81.3M
-
Put/Call ratio
-
3.05
-
Number of buys
-
127
-
Number of sells
-
-101
-
Price
-
$112.00
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2020
276 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2020.
CONMED Corp - Common Stock (CNMD) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.5M shares
of 30.9M outstanding shares and own 98.63% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.48M shares), VANGUARD GROUP INC (3M shares), Champlain Investment Partners, LLC (1.69M shares), EARNEST PARTNERS LLC (1.58M shares), STATE STREET CORP (972K shares), DIMENSIONAL FUND ADVISORS LP (964K shares), Invesco Ltd. (930K shares), PRINCIPAL FINANCIAL GROUP INC (917K shares), MACQUARIE GROUP LTD (776K shares), and Capital Research Global Investors (718K shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.